Clinical Trials Browser

Adenocarcinoma × Epirubicin × Clear all

NCT00215644 2018-11-02

MATRIX EG

Phase 2 Completed

72 enrolled 7 charts

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT00140075 2011-05-26

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

Phase 3 Completed

Adenocarcinoma